Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Climacteric ; 14(1): 171-80, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20450413

RESUMO

OBJECTIVES: To evaluate the relationships among measures of hot flushes, perceived hot flush interference, sleep disturbance, and measures of quality of life while controlling for potential covariates (patient and treatment variables). METHODS: Breast cancer survivors (n = 395) due to receive aromatase inhibitor therapy provided demographic information, physiological hot flush data via sternal skin conductance monitoring, hot flush frequency via written diary and electronic event marker, hot flush severity and bother via written diary, and questionnaire data via the Hot Flash Related Daily Interference Scale, Pittsburgh Sleep Quality Index, the EuroQOL, Hospital Anxiety and Depression Scale and the Center for Epidemiologic Studies Depression Scale. RESULTS: Confirmatory factor analysis supported a two-factor model for hot flush symptoms (frequency and severity). Although there was strong convergence among self-reported hot flush measures, there was a high degree of unexplained variance associated with physiological measures. This suggests that self-report and physiological measures do not overlap substantially. The structural model showed that greater hot flush frequency and severity were directly related to greater perceived interference with daily life activities. Greater perceived interference, in turn, directly predicted greater sleep disruption, which predicted lower perceived health state and more symptoms of anxiety and depression. CONCLUSIONS: Findings suggest hot flush interference may be the most appropriate single measure to include in clinical trials of vasomotor symptom therapies. Measuring and ameliorating patients' perceptions of hot flush interference with life activities and subjective sleep quality may be the most direct routes to improving quality of life.


Assuntos
Neoplasias da Mama/psicologia , Análise Fatorial , Fogachos/psicologia , Modelos Biológicos , Qualidade de Vida , Ansiedade/psicologia , Inibidores da Aromatase/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Depressão/psicologia , Feminino , Resposta Galvânica da Pele , Nível de Saúde , Humanos , Pessoa de Meia-Idade , Monitorização Ambulatorial , Índice de Gravidade de Doença , Transtornos do Sono-Vigília/psicologia , Inquéritos e Questionários , Sobreviventes
2.
Toxicol Appl Pharmacol ; 147(2): 399-410, 1997 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9439735

RESUMO

Copper gallium diselenide (CGS), copper indium diselenide (CIS), and cadmium telluride (CdTe) are novel compounds used in the photovoltaic and semiconductor industries. This study was conducted to characterize the relative toxicities of these compounds and to evaluate the pulmonary absorption and distribution after intratracheal instillation. Female Sprague-Dawley rats were administered a single equimolar dose (70 mM) of CGS (21 mg/kg), CIS (24 mg/kg), CdTe (17 mg/kg), or saline by intratracheal instillation. Bronchoalveolar lavage fluid (BALF) protein, fibronectin, inflammatory cells, lung hydroxyproline, and tissue distribution were measured 1, 3, 7, 14, and 28 days after instillation. Relative lung weights were significantly increased in CIS- and CdTe-treated rats at most time points. Inflammatory lesions in the lungs consisting of an influx of macrophages, lymphocytes, and PMNs were most severe in CdTe-treated rats, intermediate in CIS-treated rats, and minimal in rats receiving CGS. Hyperplasia of alveolar type 2 cells was present in CIS- and CdTe-treated rats and was greatest in CdTe-treated rats. Pulmonary interstitial fibrosis was observed in CdTe-treated rats at all time points. All three compounds caused marked increases in total BALF cell numbers, with the greatest increase observed in CIS-treated rats. BALF protein, fibronectin, and lung hydroxyproline were significantly increased in all treated animals and were highest in CdTe-treated animals. There was no apparent pulmonary absorption or tissue distribution of CGS. Indium levels increased in extrapulmonary tissues of CIS-treated rats, although Cu and Se levels remained unchanged. CdTe was absorbed from the lung to a greater extent than CGS and CIS. Cd and Te levels decreased in the lung and increased in extrapulmonary tissues. Of these compounds CdTe presents the greatest potential health risk because it causes severe pulmonary inflammation and fibrosis and because it is readily absorbed from the lung may potentially cause extrapulmonary toxicity.


Assuntos
Compostos de Cádmio/metabolismo , Compostos de Cádmio/toxicidade , Cobre/metabolismo , Cobre/toxicidade , Gálio/metabolismo , Gálio/toxicidade , Índio/metabolismo , Índio/toxicidade , Pulmão/efeitos dos fármacos , Selênio/metabolismo , Selênio/toxicidade , Telúrio/metabolismo , Telúrio/toxicidade , Absorção , Animais , Peso Corporal/efeitos dos fármacos , Líquido da Lavagem Broncoalveolar/química , Líquido da Lavagem Broncoalveolar/citologia , Feminino , Fibronectinas/química , Hidroxiprolina/metabolismo , Rim/efeitos dos fármacos , Rim/patologia , Pulmão/metabolismo , Pulmão/patologia , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Baço/efeitos dos fármacos , Baço/patologia
3.
Environ Res ; 71(1): 16-24, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8757234

RESUMO

Acute toxicity studies were conducted on copper gallium diselenide (CGS), copper indium diselenide (CIS), and cadmium telluride (CT), three novel compounds used in the photovoltaic and semiconductor industries. Female Sprague-Dawley rats (six rats/dose) were administered 0, 12, 25, 50, or 100 mg/kg body wt of CGS, CIS, or CT by intratracheal instillation. At 72 hr after treatment, body weight gain was significantly decreased in the 100 mg/kg CIS group and in all CT dose groups. Lung weights were increased in most chemical-treated rats, with CT causing the greatest increase. Total numbers of cells in bronchoalveolar lavage fluid (BALF) were significantly increased in treated rats and were greatest in the 100 mg/kg CIS group. Differential cell counts of BALF demonstrated a marked decrease in the percentage of alveolar macrophages and an increase in the percentage of polymorphonuclear leukocytes in all dose groups of all three chemicals. Slight to moderate increases in lactate dehydrogenase activity were observed in BALF from CGS- and CIS-treated rats; marked increases were observed in CT-treated rats. BALF protein was significantly increased in rats treated with CIS and CT. Microscopic examination revealed lymphoid hyperplasia in lungs of rats treated with all three chemicals. CT caused necrosis of the terminal bronchiolar epithelium and epithelium of the alveolar duct region with inflammation, prominent fibrin exudates, and type II cell hyperplasia. CGS and CIS also caused intraalveolar inflammation and type II cell hyperplasia, but did not cause the necrosis and fibrin exudate observed in lungs of CT-treated rats. Based on changes in lung weight, BALF indices, and histopathology, CT was the most toxic for the lung; CIS had intermediate toxicity and CGS was the least toxic. The solubilities of CGS and CIS were relatively low and similar at both pH levels and do not readily explain the observed differences in pulmonary toxicity. The solubility of CdTe was considerably greater than that of CGS and CIS and likely contributed to the greater toxicity of this compound.


Assuntos
Compostos de Cádmio/toxicidade , Cobre/toxicidade , Gálio/toxicidade , Índio/toxicidade , Pulmão/efeitos dos fármacos , Selênio/toxicidade , Telúrio/toxicidade , Animais , Peso Corporal , Líquido da Lavagem Broncoalveolar/citologia , Compostos de Cádmio/administração & dosagem , Relação Dose-Resposta a Droga , Feminino , L-Lactato Desidrogenase/metabolismo , Pulmão/enzimologia , Pulmão/patologia , Tamanho do Órgão , Ratos , Ratos Sprague-Dawley , Telúrio/administração & dosagem , Traqueia
4.
Adm Soc Work ; 7(2): 1-10, 1983.
Artigo em Inglês | MEDLINE | ID: mdl-10310102

RESUMO

Health and social service organizations in the United States are experiencing decline in financial resources. Little is known about the management of such decline. Forty-three executives of health and human service organizations were interviewed to study their experience with cutback management. The political strategies used by the executives to cope with cutbacks are described.


Assuntos
Financiamento Governamental/tendências , Serviços de Saúde/economia , Política , Serviço Social/economia , Coleta de Dados , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...